These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 2129517
1. Reduction of morbidity in hepatosplenic schistosomiasis mansoni after treatment with praziquantel: a long term study. Domingues AL, Coutinho AD. Rev Soc Bras Med Trop; 1990; 23(2):101-7. PubMed ID: 2129517 [Abstract] [Full Text] [Related]
2. [Treatment of hepatosplenic schistosomiasis mansoni with praziquantel]. Coutinho AD, Domingues AL, Florêncio JN, Almeida ST. Rev Inst Med Trop Sao Paulo; 1984; 26(1):38-50. PubMed ID: 6379831 [No Abstract] [Full Text] [Related]
3. Praziquantel in the treatment of the hepatosplenic form of Schistosomiasis mansoni. da Silva LC, Sette H, Christo CH, Sáez-Alquezar A, Carneiro CR, Lacet CM, Ohtsuki N, Raia S. Arzneimittelforschung; 1981; 31(3a):601-3. PubMed ID: 7195256 [Abstract] [Full Text] [Related]
4. Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment. Boisier P, Ramarokoto CE, Ravaoalimalala VE, Rabarijaona L, Serieye J, Roux J, Esterre P. Trans R Soc Trop Med Hyg; 1998; 92(4):451-3. PubMed ID: 9850407 [Abstract] [Full Text] [Related]
5. Treatment of hepatosplenic Schistosomiasis mansoni with praziquantel. Preliminary report on tolerance and efficacy. Coutinho A, Domingues AL, Neves J, Almeida ST. Arzneimittelforschung; 1983; 33(5):787-91. PubMed ID: 6683560 [No Abstract] [Full Text] [Related]
6. Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel. Gryseels B, Nkulikyinka L. Trans R Soc Trop Med Hyg; 1989; 83(2):219-28. PubMed ID: 2514474 [Abstract] [Full Text] [Related]
7. Comparative clinical and ultrasound study of egg-negative and egg-positive individuals from Schistosoma mansoni low morbidity endemic areas, and hospitalized patients with hepatosplenic disease. Magalhães TV, Gazzinelli G, Alvarez MC, Lima e Silva FC, Fraga LA, Silveira AM, Gazzinelli A, Bethony J, LoVerde P, Caldas IR, Correa-Oliveira R, Prata A. Rev Soc Bras Med Trop; 2005; 38(1):33-7. PubMed ID: 15717092 [Abstract] [Full Text] [Related]
11. Hepatosplenic schistosomiasis: playing hide-and-seek with an elusive parasite. Baekby M, Glerup H, Stribolt K, Tarp B. BMJ Case Rep; 2017 Aug 16; 2017():. PubMed ID: 28814579 [Abstract] [Full Text] [Related]
17. Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda. Frenzel K, Grigull L, Odongo-Aginya E, Ndugwa CM, Loroni-Lakwo T, Schweigmann U, Vester U, Spannbrucker N, Doehring E. Am J Trop Med Hyg; 1999 Jun 16; 60(6):927-31. PubMed ID: 10403322 [Abstract] [Full Text] [Related]
18. Alternate chemotherapy in experimental schistosomiasis. Ismail MM, Farghaly AM, Hassan MM, Youssef SM, Mohamed FE. J Egypt Soc Parasitol; 1992 Aug 16; 22(2):321-6. PubMed ID: 1500769 [Abstract] [Full Text] [Related]